ArticleBiomarker research2025

Clinical stabilization of a highly refractory acute myeloid leukaemia under individualized treatment with immune response modifying drugs by in vivo generation of dendritic cells of leukaemic origin (DCleu) and modulation of effector cells and immune escape mechanisms.

Giuliano Filippini Velázquez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.